Entity
  • SEQENS

    Created in 2003


  • Up & running (A)
    Existing signals show a regular activity
  • Social networks

    381 573 42,711
  • Entity types

  • Location

    21 Chem. de la Sauvegarde, 69130 Écully, France

    Écully

    France

  • Employees

    Scale: 1001-5000

    Estimated: 1,305

  • SIREN

    444465736
  • Engaged catalyst

    39
    0 0
  • Added in Motherbase

    4 years, 1 month ago
Description
  • Value proposition

    Our science for your future

    SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients.

    The group generates a revenue of 1.1 MM€ and operates 16 manufacturing plants and 9 R&D centers in Europe, North America and Asia. 3,300 employees contribute to the success of SEQENS, among which 350 scientists, engineers and experts who develop tailor-made solutions for our customers.

    SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies.


    Pharmaceutical Synthesis, Specialty Ingredients, Cosmetics, Custom Specialties, R&D, CDMO, CRDO, Generics, Innovative Pharmaceuticals, and Personnal Care

  • Original language

    Our science for your future

    Seqens est un leader mondial de la synthèse pharmaceutique et des ingrédients de spécialité.

    Le groupe génère un chiffre d'affaires de 1.1 milliard d'€ et exploite 16 sites de production ainsi que 9 centres de R&D en Europe, en Amérique du Nord et en Asie. 3 300 collaborateurs contribuent au succès de Seqens, parmi lesquels plus de 350 scientifiques, ingénieurs et experts qui développent des solutions sur mesure pour nos clients.

    Seqens est un acteur intégré qui offre un large portefeuille de principes actifs, d'intermédiaires pharmaceutiques et d'ingrédients de spécialité. Nous développons et industrialisons les molécules les plus exigeantes, en prenant appui sur notre capacité à innover, à développer et à mettre en œuvre les meilleures technologies disponibles.

  • Pharmaceutical Solutions, Personal Care & Specialty Ingredients - SEQENS

    SEQENS is an integrated global leader in Health, Personal Care and Specialty Ingredients with 16 production sites and 9 R&D centres across the world,

  • https://www.seqens.com/
Catalyst interactions
Catalyst TypeTweets Articles
Axel'One
Axel'One
Research Services
Axel'One
Research Services
Other

20 Sep 2023


Medicen Paris Region
Medicen Paris Region
Public business cluster, French Cluster, Civic and Social Organizations
Medicen Paris Region
Public business cluster, French Cluster, Civic and Social Organizations
Other

21 Jun 2024


Novartis
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Other

27 Nov 2023


Huawei
Huawei
Electricals, Telecommunications
Huawei
Electricals, Telecommunications
Other

12 Jul 2023


Accenture
Accenture
Consulting, audit, Business Consulting and Services
Accenture
Consulting, audit, Business Consulting and Services
Other

12 Jul 2023


Salesforce
Salesforce
IT services, Internet
Salesforce
IT services, Internet
Other

19 Jul 2023


La French Tech
La French Tech
Media, Government Administration
La French Tech
Media, Government Administration
Other

12 Jul 2023


European Parliament
European Parliament
European Union, Political Organizations
European Parliament
European Union, Political Organizations
Other

13 Mar 2025


UN Africa Renewal
UN Africa Renewal
International development, International Affairs
UN Africa Renewal
International development, International Affairs
Other

5 Jun 2024


bioMérieux
bioMérieux
Biotechnology, Biotechnology Research
bioMérieux
Biotechnology, Biotechnology Research
Other

24 Jun 2023


Social network dynamics
Loading...